Cardiovascular Sciences, Inc. (CVSC)

Market Cap	1.78K
Revenue (ttm)	256.68K +849.6%
Net Income	218.97K
EPS	0.01
Shares Out	17.80M
PE Ratio	0.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,379
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.000001 - 0.0001
Beta	-48.36
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Cardiovascular Sciences

Cardiovascular Sciences, Inc., a technology company, focuses on the development of medical products. Its products include Anti Adhesion Technology products to prevent post surgical scarring; Pyruvate Therapy, a patented method for treating patients suffering from cardiac trauma, such as ischemic reperfusion injury, heart failure, and bypass surgery; Thromboresistant Coating that prevents blood clot formation on medical devices; a biocompatible Human Vascular Tissue Equivalent for artery replacement during heart surgeries; and patented Aortic Ca...

• Industry: Personal Products & Services
• Sector: Consumer Discretionary
• CEO: Larry Hooper
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: CVSC

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 7, 2026

Data Sources Report a data error